Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   
 

Abstract | Full HTML Article | PDF ecancer 11 723 / https://doi.org/10.3332/ecancer.2017.723

Short Communication

Clinical response in patients with ovarian cancer treated with metronomic chemotherapy

Ovarian cancer (OC) is the leading cause of death from gynaecological cancer. It is extremely hard to diagnose in the early stages and around 70% of patients present with advanced disease. Metronomic chemotherapy (MCT) is described as the chronic administration of, generally low, equally spaced, doses of chemotherapeutic drugs with therapeutic efficacy and low toxicity. This is an effective and low-cost way to treat several types of tumours, including ovarian cancer. Here, we present six cases of advanced ovarian cancer treated with MCT with low doses of cyclophosphamide, which showed clinical response and stable disease.

Keywords: ovarian cancer, metronomic chemotherapy, cyclophosphamide

Loading Article Metrics ... Please wait

Related articles

Case Report: Lasting pathologic complete response to chemotherapy for ovarian cancer after receiving antimalarials for dermatomyositis

Abstract | Full Article | PDF Published: 22 May 2018 / https://doi.org/10.3332/ecancer.2018.837

Case Report: Multimodality management of leiomyosarcoma of the cervix

Abstract | Full Article | PDF Published: 30 Apr 2018 / https://doi.org/10.3332/ecancer.2018.830

Conference Report: Highlights from the 10th Breast, Gynaecological and Immunotherapy International Cancer Conference (BGICC), 18–19 January 2018, Cairo, Egypt

Abstract | Full Article | PDF Published: 22 Mar 2018 / https://doi.org/10.3332/ecancer.2018.820

Case Report: Cauda equina syndrome secondary to leptomeningeal metastases from recurrent primary peritoneal carcinoma

Abstract | Full Article | PDF Published: 26 Feb 2018 / https://doi.org/10.3332/ecancer.2018.814

Case Report: Palliative hysterectomy for vaginal bleeding from breast cancer metastatic to the uterus

Abstract | Full Article | PDF Published: 14 Feb 2018 / https://doi.org/10.3332/ecancer.2018.811



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence